L. Cirillo, A. Silipo, E. Bedini, M. Parrilli
FULL PAPER
Second eluted compound 15b (12.1 mg, 34%) was recovered as a
white powder. [α]D = +84.1 (c = 1.5; CH2Cl2). 1H NMR (400 MHz,
CDCl3 ): δ = 7 . 4 6– 7. 35 (m, 5 H, Ar-H), 5. 87 (m, 1 H,
OCH2CH=CH2), 5.52 (s, 1 H, CHPh), 5.30 (br. d, Jvic = 17.2 Hz,
96.5 (C-1A, C-1B, C-1C), 80.6, 79.8, 79.4, 77.9, 76.0, 74.7, 73.6, 73.3,
72.2, 71.7, 69.1, 69.0, 68.9, 68.5, 66.7, 65.1, 62.9, 61.2, 55.0 (C-2A,
C-2B, C-2C, C-3A, C-3B, C-3C, C-4A, C-4B, C-4C, C-5A, C-5B, C-5C,
C-6A, C-6B, 3 ϫ OCH2Ph, 2 ϫ OCH2CH=CH2), 16.3 (C-6C) ppm.
1 H, trans OCH2CH=CHH), 5.23 (br. d, Jvic = 10.3 Hz, 1 H, cis MALDI TOF-MS: calcd. for C61H66N2O16 1082.44; found 1105.21
OCH2CH=CHH), 5.09 (t, J3,2 = J3,4 = 10.0 Hz, 1 H, 3-H), 4.90 (d,
[M + Na]+. C61H66N2O16 (1082.44): calcd. C 67.64, H 6.14, N 2.59;
J1,2 = 3.6 Hz, 1 H, 1-H), 4.85 (d, JH,NH = 9.6 Hz, 1 H, NH), 4.27 found C 67.48, H 6.00, N 2.50.
(dd, Jgem = 10.2, J6a,5 = 4.8 Hz, 1 H, 6a-H), 4.18 (m, 2 H, 2-H,
N-[3-O-(2,3,4-Tri-O-benzyl-α-
ylidene-2-deoxy-α- -glucopyranos-2-yl]-NЈ-(1-O-allyl-4,6-O-benzyl-
idene-2-deoxy-α- -glucopyranos-2-yl)urea (18): A solution of com-
L-fucopyranosyl)-1-O-allyl-4,6-O-benz-
OCHHCH=CH2), 4.00 (dd, Jgem = 12.8, Jvic = 6.1 Hz, 1 H,
OCHHCH=CH2), 3.91 (dt, J5,4 = J5,6b = 9.9, J5,6a = 4.8 Hz, 1 H,
5-H), 3.75 (m, 5 H, 4-H, 6b-H, OCH3) ppm. 13C NMR (100 MHz,
CDCl3): δ = 156.2, 155.9 (COOCH3, NCON), 137.0 (Cipso), 133.2
(OCH 2 CH= CH 2 ) , 1 2 9 . 1 , 1 2 8 . 3 , 1 2 6 . 2 ( C - A r ) , 1 1 8 . 2
(OCH2CH=CH2), 101.6 (CHPh), 97.6 (C-1), 79.1, 74.5, 68.8, 68.7,
62.9, 55.1, 53.4 (C-2, C-3, C-4, C-5, C-6, OCH2CH=CH2, OCH3)
ppm. MALDI TOF-MS: calcd. for C37H44N2O15 756.27; found
779.38 [M + Na]+. C37H44N2O15 (756.27): calcd. C 58.72, H 5.86,
N 3.70; found C 58.50, H 5.68, N 3.65.
D
D
pound 17 (36.6 mg, 33.8 µmol) in 3:1 (v/v) 1,4-dioxane/water
(2.1 mL) was treated with triethylamine (260 µL). After 30 h stir-
ring at 80 °C, silica gel (600 mg) was added. The mixture was imme-
diately cooled to room temp. and concentrated. Flash chromatog-
raphy (toluene/ethyl acetate, 6:1 to 2:1) afforded 18 (20.8 mg, 58%)
as white amorphous crystals. [α]D = –3 (c = 0.7; CH2Cl2). 1H NMR
(400 MHz, CDCl3): δ = 7.40–7.27 (m, 25 H, Ar-H), 5.88 (m, 1 H,
OCH2CH=CH2), 5.78 (m, 1 H, OCH2CH=CH2), 5.54 (s, 2 H, 2 ϫ
CHPh), 5.30 (dd, Jv i c = 17.2, Jg e m = 1.4 Hz, 1 H, trans
OCH2CH=CHH), 5.28 (d, J1,2 = 3.1 Hz, 2 H, 1A-H, 1B-H), 5.23
(dd, Jvic = 10.4, Jgem = 1.4 Hz, 1 H, cis OCH2CH=CHH), 5.17 (dd,
Jvic = 17.2, Jgem = 1.4 Hz, 1 H, trans OCH2CH=CH2), 5.14 (dd,
Jvic = 10.4, Jgem = 1.4 Hz, 1 H, cis OCH2CH=CHH), 5.05 (br. s, 2
Alternatively, compound 15b could be obtained by dissolving 5
(42.4 mg, 61.3 µmol) in chloroform (1.4 mL) and then treating it
with methanol (0.6 mL) and triethylamine (0.1 mL). The solution
was stirred at room temp. for two days. The reaction was quenched
by adding a few drops of 0.1 HCl. The mixture was immediately
diluted with CH2Cl2 (25 mL) and washed with water. The organic
layer was collected, dried and concentrated. Column chromatog-
raphy (toluene/ethyl acetate, 7:1 to 5:1) of the residue afforded 15b
(24.9 mg, 54%).
H, 2 ϫ NH), 5.01 (d, J1,2 = 3.8 Hz, 1 H, 1C-H), 4.89 (d, Jgem
=
11.5 Hz, 1 H, OCHHPh), 4.82 (d, Jgem = 11.9 Hz, 1 H, OCHHPh),
4.75 (s, 2 H, OCH2Ph), 4.65 (d, Jgem = 11.5 Hz, 1 H, OCHHPh),
4.57 (d, Jgem = 11.9 Hz, 1 H, OCHHPh), 4.28 (dd, J2,3 = 10.0, J2,1
= 3.5 Hz, 1 H, 2A-H), 4.23 (dd, J2,3 = 10.0, J2,1 = 3.5 Hz, 1 H, 2B-
H), 4.16 (dd, Jgem = 13.4, Jvic = 6.8 Hz, 1 H, OCHHCH=CH2),
4.09–3.68 (m, 16 H, 2C-H, 3A-H, 3B-H, 3C-H, 4A-H, 4B-H, 5A-H,
5B-H, 5C-H, 6aA-H, 6bA-H, 6aB-H, 6bB-H, 3 ϫ OCHHCH=CH2),
3.53 (d, J4,3 = 2.0 Hz, 1 H, 4C-H), 0.96 (d, J6,5 = 6.4 Hz, 3 H, 6C-
H) ppm. 13C NMR (50 MHz, CDCl3): δ = 158.9 (NCON), 138.7,
138.5, 137.6, 137.3, 137.1 (3 ϫ Cipso Bn, 2 ϫ Cipso benzylidene),
133.7, 133.2 (2 ϫ OCH2CH=CH2), 129.0–125.9 (C-Ar), 118.4,
117.9 (2 ϫ OCH2CH=CH2), 101.7, 101.1 (2 ϫ CHPh), 97.9, 97.4,
97.3 (C-1A, C-1B, C-1C), 81.7, 81.5, 79.2, 79.1, 77.5, 74.9, 74.5, 73.7,
73.3, 71.8, 71.7, 68.8, 68.7, 68.6, 67.2, 63.0, 62.5, 55.6, 55.1 (C-2A,
C-2B, C-2C, C-3A, C-3B, C-3C, C-4A, C-4B, C-4C, C-5A, C-5B, C-5C,
C-6A, C-6B, 3 ϫ OCH2Ph, 2 ϫ OCH2CH=CH2), 16.5 (C-6C) ppm.
MALDI TOF-MS: calcd. for C60H68N2O15 1056.46; found 1078.61
[M + Na]+. C60H68N2O15 (1056.46): calcd. C 68.17, H 6.48, N 2.65;
found C 68.08, H 6.42, N 2.60.
N-[3-O-(2,3,4-Tri-O-benzyl-α-
ylidene-2-deoxy-α- -glucopyranos-2-yl]-NЈ-(1-O-allyl-4,6-O-benzyl-
idene-2,3-N,O-carbonyl-2-deoxy-α- -glucopyranos-2-yl)urea (17): A
L-fucopyranosyl)-1-O-allyl-4,6-O-benz-
D
D
mixture of 14a (39.0 mg, 58.6 µmol) and 16 (70.8 mg, 117 µmol)
was coevaporated three times with toluene, the residue was dried
and then mixed with freshly activated molecular sieves (AW-300,
4 Å), suspended under argon in 1:1 (v/v) CH2Cl2/THF (1.5 mL).
The mixture was stirred at –30 °C for 15 min. A solution of
TMSOTf in CH2Cl2 (24.6 mg/mL, 27.4 µL, 3.0 µmol) was then
added. The mixture was stirred for 75 min at –30 °C, then a few
drops of Et3N were added. The mixture was filtered through a Ce-
lite pad and concentrated. The residue was subjected to column
chromatography (toluene/ethyl acetate, 12:1 to 8:1) to give 17
(48.1 mg, 76%) as a colorless oil. [α]D = +23.1 (c = 1.7; CH2Cl2).
1H NMR (400 MHz, CDCl3): δ = 8.08 (d, JH,NH = 10.0 Hz, 1 H,
NH), 7.39–7.25 (m, 25 H, Ar-H), 5.86 (m, 1 H, OCH2CH=CH2),
5.69 (m, 2 H, 1A-H, OCH2CH=CH2), 5.54 (s, 1 H, CHPh), 5.51 (s,
1 H, CHPh), 5.35 (d, J1,2 = 3.6 Hz, 1 H, 1C-H), 5.31 (dd, Jvic
17.2, Jgem = 1.5 Hz, 1 H, trans OCH2CH=CHH), 5.22 (dd, Jvic
10.5, Jgem = 1.5 Hz, 1 H, cis OCH2CH=CHH), 5.09 (dd, Jvic
17.0, Jgem = 1.5 Hz, 1 H, trans OCH2CH=CH2), 5.06 (dd, Jvic
10.5, Jgem = 1.5 Hz, 1 H, cis OCH2CH=CH2), 4.89 (d, Jgem
=
=
=
=
=
N-(1-O-Allyl-3-O-α-
yl)-NЈ-(1-O-allyl-2-deoxy-α-
tion of 18 (10.0 mg, 9.5 µmol) in 9:1 (v/v) MeOH/HCOOH
(500 µL) was treated with Pd/C (3 mg) under an Ar atmosphere.
After 1 h in an ultrasound bath, the mixture was filtered through
L
-fucopyranosyl-2-deoxy-α-
D-glucopyranos-2-
D-glucopyranos-2-yl)urea (19): A solu-
11.5 Hz, 1 H, OCHHPh), 4.87 (d, J1,2 = 3.5 Hz, 1 H, 1B-H), 4.83 a Celite pad and concentrated. The residue was lyophilized to give
(d, Jgem = 11.7 Hz, 1 H, OCHHPh), 4.73 (d, Jgem = 11.6 Hz, 1 H, pure 19 (4.2 mg, 72%) as a white foam. [α]D = +37 (c = 0.3; H2O).
OCHHPh), 4.66 (d, Jgem = 11.7 Hz, 1 H, OCHHPh), 4.65 (t, J3,4
J3,2 = 10.0 Hz, 1 H, 3A-H), 4.56 (d, Jgem = 11.6 Hz, 1 H,
=
1H NMR (400 MHz, D2O): δ = 5.04 (d, J1,2 = 3.9 Hz, 1 H, 1-H),
4.89 (d, J1,2 = 3.4 Hz, 1 H, 1-H), 4.82 (d, J1,2 = 3.6 Hz, 1 H, 1-H),
OCHHPh), 4.55 (d, Jgem = 11.5 Hz, 1 H, OCHHPh), 4.35 (dt, 4.34 (q, J5,6 = 6.6 Hz, 1 H, 5C-H), 3.88–3.40 (m, 19 H, 2A-H, 2B-
J2,3 = J2,NH = 10.0, J2,1 = 3.5 Hz, 1 H, 2B-H), 4.31–4.17 (m, 5 H,
2A-H, 6aA-H, 6bA-H, OCH2CH=CH2), 4.12 (q, J5,6 = 6.4 Hz, 1 H,
5C-H), 4.05–3.72 (m, 11 H, 2C-H, 3B-H, 3C-H, 4A-H, 4B-H, 5A-H,
H, 2C-H, 3A-H, 3B-H, 3C-H, 4A-H, 4B-H, 4C-H, 5A-H, 5B-H, 6A-
H, 6B-H, 2 ϫ OCH2CH2CH3), 1.62 (m, 4 H, 2 ϫ OCH2CH2CH3),
1.16 (d, J6,5 = 6.6 Hz, 3 H, 6C-H), 0.93 (t, Jvic = 7.4 Hz, 6 H, 2
5B-H, 6aB-H, 6bB-H, OCH2CH=CH2), 3.49 (d, J4,3 = 2.0 Hz, 1 H, ϫ OCH2CH2CH3) ppm. 13C NMR (100 MHz, D2O): δ = 160.1
4C-H), 0.88 (d, J6,5 = 6.4 Hz, 3 H, 6C-H) ppm. 13C NMR (NCON), 100.0, 98.3 (C-1A, C-1B, C-1C), 79.0, 72.6, 72.5, 70.9,
(100 MHz, CDCl3): δ = 154.9, 152.4 (OCON, NCON), 139.0,
138.6, 138.2, 137.3, 136.4 (3 ϫ Cipso Bn, 2 ϫ Cipso benzylidene),
133.4, 133.0 (2 ϫ OCH2CH=CH2), 129.3–125.9 (C-Ar), 118.0,
70.8, 70.7, 69.3, 68.9, 67.8, 61.4 (C-2C, C-3A, C-3B, C-3C, C-4A, C-
4B, C-4C, C-5A, C-5B, C-5C, C-6A, C-6B, OCH2CH2CH3), 55.0, 54.7
(C-2A, C-2B), 22.8 (OCH2CH2CH3), 16.0 (C-6C), 10.7
117.9 (2 ϫ OCH2CH=CH2), 101.6, 101.4 (2 ϫ CHPh), 97.2, 96.6, (OCH2CH2CH3) ppm. MALDI TOF-MS: calcd. for C25H46N2O15
4072
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 4062–4074